GZMB and malignant colon neoplasm: In the current study, we have assessed the ability of [18F]AlF-mNOTA-GZP (Fig. 1A), a peptide probe targeting granzyme B to serve as a PET imaging biomarker of combined ICI/chemotherapy in a syngeneic mouse model of colon cancer.